The LCCC internal and external advisory groups provided invaluable guidance in planning and evaluation of all the major initiatives. The new Director continued to expand the decision-making and advisory groups to include: The Senior Leadership Team, which is composed of the Director and (8) Associate Directors,meets weekly to evaluate progress in strategic LCCC initiatives. The Program Planning Committee, which meets bi-weekly to evaluate progress of all important initiatives and includes institutional and Research Program Leaders, plus the Senior Leadership Team. The Internal Advisory Board, which is comprised of institutional leaders including the Chancellor; the Deans of the schools of Medicine, Pharmacy, and Public Health; and external advisors, and which meets with the Director at least quarterly. The Scientific Advisory Board (SAB), which is comprised of expert external advisors, and which was expanded with the addition of 7 new members in 2014 to provide additional expertise in specific areas such as cancer genomics, tumor immunology, administration, patient advocacy and biostatistics. There are now 16 members on the SAB with complementary expertise in basic, clinical, translational, and population sciences and administration. The SAB meets annually or more often, at the UNC LCCC. With careful planning and critical input from advisory groups, the Director initiated a new 5 year strategic planning process, reorganized Center Research Program membership, Shared Resource Leadership, and created working groups and committees to continue improving oversight and governance. These coordinated teams of advisors provide critical advice and guidance, both annually in the fall and ad-hoc as required, ensuring that LCCC most effectively set priorities and pursues objectives that promote basic, clinical, prevention and translational research at the Center.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of North Carolina Chapel Hill
Chapel Hill
United States
Zip Code
Ziehr, Benjamin; Vincent, Heather A; Moorman, Nathaniel J (2016) Human Cytomegalovirus pTRS1 and pIRS1 Antagonize Protein Kinase R To Facilitate Virus Replication. J Virol 90:3839-48
Xiao, Ping-Jie; Mitchell, Angela M; Huang, Lu et al. (2016) Disruption of Microtubules Post-Virus Entry Enhances Adeno-Associated Virus Vector Transduction. Hum Gene Ther 27:309-24
White, Alexandra J; Bradshaw, Patrick T; Herring, Amy H et al. (2016) Exposure to multiple sources of polycyclic aromatic hydrocarbons and breast cancer incidence. Environ Int 89-90:185-92
Xu, Yang; Chaudhury, Arindam; Zhang, Ming et al. (2016) Glycolysis determines dichotomous regulation of T cell subsets in hypoxia. J Clin Invest 126:2678-88
He, Zhijian; Wan, Xiaomeng; Schulz, Anita et al. (2016) A high capacity polymeric micelle of paclitaxel: Implication of high dose drug therapy to safety and in vivo anti-cancer activity. Biomaterials 101:296-309
Moracco, Kathryn E; Morgan, Jennifer C; Mendel, Jennifer et al. (2016) ""My First Thought was Croutons"": Perceptions of Cigarettes and Cigarette Smoke Constituents Among Adult Smokers and Nonsmokers. Nicotine Tob Res 18:1566-74
Park, Eliza M; Deal, Allison M; Check, Devon K et al. (2016) Parenting concerns, quality of life, and psychological distress in patients with advanced cancer. Psychooncology 25:942-8
Ohkuni, Kentaro; Takahashi, Yoshimitsu; Fulp, Alyona et al. (2016) SUMO-Targeted Ubiquitin Ligase (STUbL) Slx5 regulates proteolysis of centromeric histone H3 variant Cse4 and prevents its mislocalization to euchromatin. Mol Biol Cell :
Becker, Marc A; Ibrahim, Yasir H; Oh, Annabell S et al. (2016) Insulin Receptor Substrate Adaptor Proteins Mediate Prognostic Gene Expression Profiles in Breast Cancer. PLoS One 11:e0150564
Sin, Sang-Hoon; Kang, Sun Ah; Kim, Yongbaek et al. (2016) Kaposi's Sarcoma-Associated Herpesvirus Latency Locus Compensates for Interleukin-6 in Initial B Cell Activation. J Virol 90:2150-4

Showing the most recent 10 out of 897 publications